首页> 外文期刊>The Internet Journal of Cardiovascular Research >Torsade De Pointes Caused By Concomitant Use Of Ketoconazole And Terfenadine
【24h】

Torsade De Pointes Caused By Concomitant Use Of Ketoconazole And Terfenadine

机译:酮康唑和特非那定的并用引起的扭转性肥胖

获取原文
           

摘要

A 47-year-old female developed frequent syncope eight days after the administration of oral ketoconazole and terfenadine for fungal infection and urticaria respectively. ECG at hospital admission showed prolonged QT interval and TDP. The patient had no previous history of syncope nor did she have other risk factors for TDP. Both ketoconazole and terfenadine were immediately discontinued, followed by intravenous infusion of isoprenaline (2.0 μg/min) to maintain the heart rate at 100 beats/min. TDP resolved after the management. QT interval returned to normal range within 5 days of admission. She had no recurrence in TDP or QT prolongation during the follow up of six months. Conclusions: Terfenadine prolongs QT interval and leads to life-threatening ventricular arrhythmia. This cardiac toxicity may be enhanced by concomitant use of liver enzyme inhibitor ketoconazole.
机译:一名47岁的女性在口服酮康唑和特非那定后八天分别因真菌感染和荨麻疹而出现频繁的晕厥。入院时的心电图显示QT间期和TDP延长。该患者既没有晕厥病史,也没有其他TDP危险因素。立即停用酮康唑和特非那定,然后静脉输注异丙肾上腺素(2.0μg/ min)以将心率维持在100次/ min。 TDP管理解决后。入院后5天内QT间隔恢复到正常范围。在六个月的随访中,她的TDP或QT延长无复发。结论:特非那定延长QT间期并导致危及生命的室性心律失常。伴随使用肝酶抑制剂酮康唑可增强这种心脏毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号